Valuation: DexCom, Inc.

Market Cap 2.96TCr 2.58TCr 2.39TCr 2.2TCr 4.14TCr 2,84800Cr 4.24TCr 29TCr 11TCr 1,39500Cr 11TCr 11TCr 4,80200Cr P/E 2026 *
31.3x
P/E 2027 * 26.2x
Enterprise Value 2.91TCr 2.55TCr 2.35TCr 2.17TCr 4.08TCr 2,80700Cr 4.17TCr 28TCr 11TCr 1,37500Cr 11TCr 11TCr 4,73300Cr EV / Sales 2026 *
5.58x
EV / Sales 2027 * 4.86x
Free-Float
93.34%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Change 5-day change 1-year change 3-year change Capi.($)
+0.74%-2.36% - - 2.96TCr
+1.87%+7.19%-16.46%-5.91% 18TCr
-0.43%-0.80%-7.07%-4.05% 11TCr
-0.03%+1.47%+4.59%+60.25% 5.99TCr
+0.66%+0.96%+37.56%+53.38% 5.2TCr
-1.10%+4.10%-12.56%-38.37% 4.36TCr
-3.21%-3.05% - - 3.36TCr
-1.16%+1.28%+61.67%-6.62% 2.53TCr
-1.49%+0.85%-3.01%-4.60% 2.12TCr
-0.91%+1.31%-3.73%-18.94% 2.07TCr
Average -0.51%+1.48%+7.62%+4.39% 5.98TCr
Weighted average by Cap. +0.18%+2.73%-1.07%+5.13%

Financials

2026 *2027 *
Net sales 522.4Cr 456.53Cr 421.27Cr 388.31Cr 731.89Cr 50TCr 748.14Cr 5.04TCr 1.98TCr 25TCr 1.96TCr 1.92TCr 85TCr 582.66Cr 509.19Cr 469.87Cr 433.1Cr 816.31Cr 56TCr 834.43Cr 5.62TCr 2.21TCr 27TCr 2.19TCr 2.14TCr 95TCr
Net income 96Cr 84Cr 77Cr 71Cr 134.42Cr 9.24TCr 137.41Cr 924.8Cr 363.74Cr 4.53TCr 360.33Cr 352.42Cr 16TCr 115.73Cr 101.14Cr 93Cr 86Cr 162.14Cr 11TCr 165.74Cr 1.12TCr 438.76Cr 5.46TCr 434.64Cr 425.1Cr 19TCr
Net Debt -43Cr -37Cr -35Cr -32Cr -60Cr -4.13TCr -61Cr -413.22Cr -162.53Cr -2.02TCr -161Cr -157.47Cr -6.96TCr -128.06Cr -111.91Cr -103.27Cr -95Cr -179.41Cr -12TCr -183.39Cr -1.23TCr -485.49Cr -6.04TCr -480.93Cr -470.38Cr -21TCr
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
76.65USD
Average target price
85.75USD
Spread / Average Target
+11.87%

Quarterly revenue - Rate of surprise